preloader

CELL THERAPY FOR ALZHEIMER’S DISEASE IN MALAYSIA

Unlocking the Potential of Cell-based Therapies Since 2017
CELL THERAPY FOR ALZHEIMER’S DISEASE IN MALAYSIA

A pioneer in cell therapy for Alzheimer’s disease, Cyrona Cell's broad and leading cell therapy expertise has transformed the lives of many individuals living with multiple different health conditions.

How Can Cell Therapy Help You?

Cyrona Cell uses Wharton’s Jelly mesenchymal cells that have been derived from infant umbilical cords as they can:

  • Cross the endothelial brain barrier
  • Identify and migrate to sites of injury
  • Encourage your existing neurons to self-repair and adapt
  • Modulate your immune system to prevent it from targeting your remaining neurons
  • Decrease inflammation to enable the body to heal
  • Protect and prevent the remaining neurons from dying
  • Transform into neurons and glia
  • Promote the formation of nerve cell axons
  • Release neuroprotective factors

 

Cellular Therapy: A Transformation Healthcare Solution

As Alzheimer’s disease is a debilitating neuropsychiatric disorder that affects the brain, the aim of cell therapy is to preserve what neurological function remains, repair and regenerate areas of damage, and to prevent amyloid beta and tau proteins from wreaking further damage and enable the brain to heal.

Scientifically-Proven Results

Year

University/Centre

Results

2011

Slovak Academy of Sciences, Slovak Republic

Helped neurons survival, increased the ability of cells to convert nutrients into energy and increase the firing rate of neurons, caused cells to transform into neurons, and increased the formation of neural nerves.

2012

Biomedical Research Institute, South Korea

Increased the production of an enzyme (neprilysin) that degrades amyloid beta and decreased amyloid beta plaques.

2012

University of Eastern Finland, Finland

Decreased amyloid beta production.

2012

First Affiliated Hospital of Soochow University, China

Improved spatial memory, increased neurotransmitter (acetylcholine) levels, and increased the formation of neural nerves.

2013

Tsinghua University, China

Significantly decreased amyloid beta production, restored learning and memory functions, and increased the brain's ability to heal by producing more microglia.

2013

Stem Cell Neuroplasticity Research Group, South Korea

Significantly decreased amyloid beta production and increased the amount of key proteins that help synapses form.

2013

Second Hospital of Shandong University, China

Improved cognitive function, increased the production of proteins that help synapses form (synapsin I), and significantly decreased amyloid beta production.

2015

Yonsei University College of Medicine, South Korea

Modulated inflammation and increased the brain's ability to heal by producing more microglia as well as decreased the tau and amyloid beta production.

2017

The Second Hospital of Shandong University and Jinan Central Hospital, China

Significantly improved spatial learning and decreased memory decline.

2017

Kunming Medical University, China

Improved early cognitive functions and daily living activities.

2018

Yonsei University College of Medicine, South Korea

Facilitated significant cognitive recovery.

 

Why is Cyrona Cell the Right Choice for You?

Achieving high standards in our work is of paramount importance to us. As such, we only produce and use premium grade passage 1 (P1) and passage 2 (P2) Wharton’s Jelly mesenchymal stem cells in all our therapy programmes. These cellular products have also been thoroughly screened and analysed in accordance with the requirements of The International Society for Cellular Therapy prior to use.

We also use the latest in cellular research and technologies to tailor our therapy programmes according to the needs of the individual. Furthermore, our microbiology and clinical team as well as our extensively experienced board-certified physicians are geared towards your safety and wellbeing.

 

 

More than 1000 people are choosing Cyrona Health

 

Start the Journey towards the Best Version of Yourself Today

All our therapy programmes are conducted using premium grade P1 and P2 Wharton’s Jelly mesenchymal cells and by board-certified experienced specialists. All patients are also provided with pre-transfusion analysis reports of any and all cellular and supplementary products used during treatment.

International patients will be provided with airport transfer services and accommodations as well as in-city transportation to and from every therapy session.

 

How Do We Proceed?

As no two people are alike, our specialists review each patient’s medical reports before developing the best treatment protocol to addresses their unique needs. Therefore, before speaking to one of our Customer Service Representatives, it is best to have the following handy:

  • Imaging results (MRI scan / CT scan / X-Ray)
  • Haematology reports (HbA1c blood test)
  • Medical evaluation reports
  • Pictures or videos of the patient (if applicable)

 

Our Facilities

Download a complimentary eBook about Alzheimer’s Disease

Download our eBook and receive our weekly in-depth and exclusive newsletter about Alzheimer’s Disease.

CELL THERAPY FOR ALZHEIMER’S DISEASE IN MALAYSIA eBook